A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.

The following is a summary of “Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal ...

Now approved in over 20 cancer types and used in earlier lines of therapy, immune checkpoint inhibitors (ICIs) have ...

War latest: Things 'look bad' for Ukraine, key figure admits - as Russia firing North Korean missiles Ukraine does not have the means to "turn the tables" in the war and will lose if it carries on ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...